Quarterly Call Option Transactions in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during . The information is specifically focused on institutions that hold call options of AbCellera Biologics Inc..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,105,200 | 544,100 | 1,649,300 | 0 | 130,600 | 130,600 | 1,518,700 | |
Q4 2021 | 7,000 | 376,300 | 383,300 | 916,000 | 17,700 | 933,700 | -550,400 | |
Q1 2022 | 398,100 | 598,100 | 996,200 | 0 | 379,900 | 379,900 | 616,300 | |
Q2 2022 | 2,207,100 | 315,000 | 2,522,100 | 111,400 | 43,100 | 154,500 | 2,367,600 | |
Q3 2022 | 590,300 | 560,200 | 1,150,500 | — | 1,150,500 | |||
Q4 2022 | 0 | 4,200 | 4,200 | 2,589,400 | 0 | 2,589,400 | -2,585,200 | |
Q1 2023 | 144,400 | 500 | 144,900 | 160,100 | 0 | 160,100 | -15,200 | |
Q2 2023 | 11,100 | 1,500 | 12,600 | 196,700 | 0 | 196,700 | -184,100 | |
Q3 2023 | 61,600 | 30,200 | 91,800 | 128,300 | 0 | 128,300 | -36,500 | |
Q4 2023 | 106,900 | 65,200 | 172,100 | 46,900 | 0 | 46,900 | 125,200 | |
Q1 2024 | — | 408,800 | 0 | 408,800 | -408,800 | |||
Q2 2024 | 100 | 10,000 | 10,100 | 35,100 | 0 | 35,100 | -25,000 | |
Q3 2024 | 41,100 | 0 | 41,100 | 51,700 | 0 | 51,700 | -10,600 |